135 related articles for article (PubMed ID: 4152920)
1. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
Bakke OM; Scheline RR
J Pharm Pharmacol; 1974 May; 26(5):377-9. PubMed ID: 4152920
[No Abstract] [Full Text] [Related]
2. Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
Sandler M; Johnson RD; Ruthven CR; Reid JL; Calne DB
Nature; 1974 Feb; 247(5440):364-6. PubMed ID: 4817854
[No Abstract] [Full Text] [Related]
3. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B
J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483
[TBL] [Abstract][Full Text] [Related]
4. L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro.
Rivera-Calimlim L; Morgan JP; Dujovne CA; Bianchine JR; Lasagna L
Biochem Pharmacol; 1971 Nov; 20(11):3051-7. PubMed ID: 5132112
[No Abstract] [Full Text] [Related]
5. Inhibition of tyrosine-3-monooxygenase by benserazide.
Reinhard JF; Shearin MD
Biochem Pharmacol; 1990 May; 39(9):1489-91. PubMed ID: 1970732
[No Abstract] [Full Text] [Related]
6. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
Tyce GM
J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
[No Abstract] [Full Text] [Related]
7. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
Viala D; Buser P
Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
[No Abstract] [Full Text] [Related]
8. Central decarboxylation and uptake of L-DOPA.
Andén NE; Engel J; Rubenson A
Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):11-26. PubMed ID: 4260798
[No Abstract] [Full Text] [Related]
9. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
Yoshimine N; Kuzuya F; Mori K; Sakamoto N
Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
[No Abstract] [Full Text] [Related]
10. The influence of L-DOPA perfusion concentrations and peripheral decarboxylase inhibition on dopa accumulation and decarboxylation in isolated perfused rat brains.
Horst WD; Bautz G; Renyi E; Spirt N
Neuropharmacology; 1973 Dec; 12(12):1145-51. PubMed ID: 4782694
[No Abstract] [Full Text] [Related]
11. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
Geissbühler F; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
Clin Chim Acta; 1971 Jun; 33(1):111-5. PubMed ID: 5097993
[No Abstract] [Full Text] [Related]
12. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
Minsker DH; Stokes AL
Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
[No Abstract] [Full Text] [Related]
13. The action L-dopa on sexual behaviour of male rats.
Da Prada M; Carruba M; Saner A; O'Brien A; Pletscher A
Brain Res; 1973 Jun; 55(2):383-9. PubMed ID: 4541349
[No Abstract] [Full Text] [Related]
14. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
Geissbühler F; Widmer J
J Clin Chem Clin Biochem; 1976 Nov; 14(11):543-7. PubMed ID: 1003116
[TBL] [Abstract][Full Text] [Related]
15. Increased neostriatal tyrosine hydroxylation during stress: role of extracellular dopamine and excitatory amino acids.
Castro SL; Sved AF; Zigmond MJ
J Neurochem; 1996 Feb; 66(2):824-33. PubMed ID: 8592158
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.
Miñano FJ; Myers RD
Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790
[TBL] [Abstract][Full Text] [Related]
17. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
Baldessarini RJ
J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
[No Abstract] [Full Text] [Related]
19. Skeletal changes induced by dopa decarboxylase inhibitor in rats.
Tanaka C; Tanaka S; Itokawa Y; Takaori S
Jpn J Pharmacol; 1973 Feb; 23(1):123-5. PubMed ID: 4541614
[No Abstract] [Full Text] [Related]
20. Synthesis of dopamine from L-3,4-dihydroxyphenylalanine by human amniotic epithelial cells.
Elwan MA
Eur J Pharmacol; 1998 Jul; 354(1):R1-2. PubMed ID: 9726639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
